What is Remote Medical Technologies?
Remote Medical Technologies specializes in cutting-edge telepathology platforms, including ROSE Now and SECTION Now. These solutions are designed to facilitate rapid on-site evaluations and frozen section assessments by enabling clinicians and pathologists to conduct high-definition image quality analyses and robotic control from any location. The company's core mission is to enhance accessibility to quality medical care by bridging geographical gaps between patients and healthcare providers, thereby improving decision-making and fostering collaboration among healthcare professionals.
How much funding has Remote Medical Technologies raised?
Remote Medical Technologies has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
What's next for Remote Medical Technologies?
With the recent injection of moderate growth capital, Remote Medical Technologies is poised to accelerate its development and deployment of telepathology solutions. The Series A/B growth stage funding indicates a strategic intent to scale its infrastructure, enhance its technological offerings, and potentially expand into new markets. This investment will likely support further innovation in remote diagnostic capabilities, aiming to solidify its position as a leader in the digital pathology and telemedicine landscape, ultimately driving greater efficiency and accuracy in medical diagnostics.
See full Remote Medical Technologies company page
